An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria

Development of a globally effective HIV-1 vaccine will need to encompass Nigeria, one of the hardest hit areas, with an estimated 3.2 million people living with HIV. This cross-sectional Institutional Review Board (IRB) approved study was conducted in 2009–12 at four market sites and two highway set...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Njoku, Ogbonnaya S., Manak, Mark M., O’Connell, Robert J., Shutt, Ashley L. W., Malia, Jennifer A., Heipertz, Richard A., Tovanabutra, Sodsai, Milazzo, Mark J., Akintunde, Gideon Akindiran, Alabi, Abraham S., Suleiman, Aminu, Ogundeji, Amos A., Kene, Terfa S., Nelson, Robbie, Ayemoba, Ojor R., Singer, Darrell E., Robb, Merlin L., Peel, Sheila A., Michael, Nelson L.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5147844/
https://ncbi.nlm.nih.gov/pubmed/27936236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166711
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados